Stock listing
Biohaven Ltd.
Selected listing: ZH6 · TRADEGATE · EUR · DE
Biohaven Ltd. (Tradegate:ZH6), Health Technology. Latest release Sep 28, 2026: Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC…
- Ticker
- Tradegate:ZH6
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tradegate
- Currency
- EUR
Latest news from Biohaven Ltd.
Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026
September 28, 2026
Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy
August 27, 2026
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload
July 20, 2026
Biohaven Announces Scientific Leadership Transitions
July 9, 2026
Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator
June 30, 2026
Events
Research Biohaven Ltd.
Alternate listings
BHVN:NYSE
US · USD
Alternate listing for Biohaven Ltd.; the primary context on this page is ZH6:TRADEGATE.
BHVN34:BMFBOVESPA
BR · BRL
Alternate listing for Biohaven Ltd.; the primary context on this page is ZH6:TRADEGATE.
BHVN:BOATS
US · USD
Alternate listing for Biohaven Ltd.; the primary context on this page is ZH6:TRADEGATE.